Womens Imaging: Page 144

MRI pinpoints important cardiomyopathy indicators
By Wayne Forrest
Monday, December 2 | 11:10 a.m.-11:20 a.m. | SSC02-05 | Room S401CDWith the right indicators, cardiac MRI can be used to detect and monitor cardiomyopathy in women after their first round of chemotherapy to treat breast cancer, say investigators from Germany.
November 5, 2019
Abbreviated breast MRI improves screening outcomes
By Kate Madden Yee
Monday, December 2 | 9:05 a.m.-9:15 a.m. | RC215-04 | Arie Crown TheaterIn this talk, Canadian researchers will discuss how an abbreviated breast MRI screening protocol in women with a high risk for breast cancer leads to fewer false positives and benign biopsies when compared with a conventional protocol -- and doesn't compromise the cancer detection rate.
November 5, 2019
Do payouts influence mammography guidelines?
By Kate Madden Yee
Do financial conflicts of interest influence clinical practice guidelines or society recommendations for screening mammography? Not really, according to a study published in the November issue of the Journal of the American College of Radiology.
November 4, 2019
2016 09 14 15 25 23 643 Dollar Sign 400
Parenchymal enhancement on MRI linked to breast cancer risk
By Kate Madden Yee
Thursday, December 5 | 11:10 a.m.-11:20 a.m. | SSQ01-05 | Room S406BIn this award-winning session, University of Pittsburgh researchers will discuss how background parenchymal enhancement imaged by dynamic contrast-enhanced breast MRI provides additional diagnostic information compared with using tumor-derived radiomics data alone.
November 4, 2019
Is DBT in younger women harmful or helpful?
By Kate Madden Yee
Wednesday, December 4 | 12:45 p.m.-1:15 p.m. | BR280-SD-WEB7 | Lakeside, BR Community, Station 7The benefits of screening digital breast tomosynthesis (DBT) in women between the ages of 40 and 49 outweigh the harms, according to research to be shared Wednesday afternoon.
November 4, 2019
Ultrasound tomography helps characterize breast cancer
By Kate Madden Yee
Wednesday, December 4 | 12:45 p.m.-1:15 p.m. | BR278-SD-WEB5 | Lakeside, BR Community, Station 5In this poster presentation, researchers will discuss how ultrasound tomography is a feasible and accurate tool for characterizing stiffness of breast lesions.
November 4, 2019
Trust whole-breast US for supplemental breast cancer screening
By Kate Madden Yee
Wednesday, December 4 | 11:50 a.m.-12:00 p.m. | SSK02-09 | Room E450AWhole-breast ultrasound performed by a technologist is an effective way to provide adjuvant screening to women with dense breast tissue, according to research to be presented on Wednesday morning.
November 4, 2019
Screening frequency key influence on recall rates
By Kate Madden Yee
Wednesday, December 4 | 11:20 a.m.-11:30 a.m. | SSK01-06 | Room E451BIn this session, researchers will share how age and race strongly influence breast cancer screening recall rates, but screening frequency and modality have greater impact.
November 4, 2019
Does DBT find more interval cancers?
By Kate Madden Yee
Wednesday, December 4 | 10:30 a.m.-10:40 a.m. | SSK01-01 | Room E451BDigital breast tomosynthesis (DBT) finds more breast cancers on screening, but it doesn't necessarily find more interval cancers, according to Norwegian researchers.
November 4, 2019
How suitable is CESM as a breast MRI alternative?
By Kate Madden Yee
Tuesday, December 3 | 10:40 a.m.-10:50 a.m. | SSG01-02 | Room S102CDAt this Tuesday morning session, German researchers will explore how suitable contrast-enhanced spectral mammography (CESM) is as an alternative to MRI for breast cancer screening.
November 4, 2019
Breast ultrasound helpful supplement even after DBT
By Kate Madden Yee
Monday, December 2 | 3:50 p.m.-4:00 p.m. | SSE02-06 | Room E451BIn this session, University of Pittsburgh researchers will discuss how whole-breast ultrasound performed by a technologist can find more cancers in women with dense breast tissue even after screening digital breast tomosynthesis (DBT) -- although it does increase the recall rate.
November 4, 2019
Higher parenchymal uptake on MBI may predict higher cancer risk
By Kate Madden Yee
Monday, December 2 | 3:30 p.m.-3:40 p.m. | SSE01-04 | Room E450AThe level of background parenchymal uptake on molecular breast imaging (MBI) can help predict future breast cancer risk in postmenopausal women, Mayo Clinic researchers have found.
November 4, 2019
Previous Page
Page 144 of 691
Next Page